• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者基于基线镓-68前列腺特异性膜抗原正电子发射断层扫描得出的原发肿瘤参数及其与临床风险分层和临床病理特征的关联

Baseline Ga-68 PSMA PET-Derived Primary Tumor Parameters in Patients with Prostate Cancer and Their Association with Clinical Risk Stratification and Clinicopathologic Features.

作者信息

Vural Topuz Özge, Aksu Ayşegül

机构信息

Department of Nuclear Medicine, University of Health Sciences, Başakşehir Cam and Sakura City Hospital, Istanbul, Türkiye.

Department of Nuclear Medicine, Atatürk Training and Research Hospital, İzmir Kâtip Çelebi University, Izmir, Türkiye.

出版信息

World J Nucl Med. 2024 Jun 14;23(4):227-233. doi: 10.1055/s-0044-1787733. eCollection 2024 Dec.

DOI:10.1055/s-0044-1787733
PMID:39677349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11637649/
Abstract

This article evaluates whether parameters derived from the gallium-68-labeled prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography/computed tomography (PET/CT) imaging studies of primary prostate cancer (PCa) lesions were associated with Gleason score (GS), D'Amico risk class, Candiolo nomograms, and the metastatic status of the disease.  We retrospectively evaluated newly diagnosed PCa patients who underwent Ga-PSMA PET/CT before therapy. Age, baseline serum prostate-specific antigen (PSA), and metastatic status were recorded. Maximal standardized uptake value (SUVmax), mean SUV (SUVmean), total lesion PSMA (TL-PSMA), and PSMA-derived tumor volume (PSMA-TV) were analyzed. The patients were grouped according to GS (GS ≤ 7 and GS ≥ 8), D'Amico risk classes (low intermediate and high-risk), and also based on their results with the Candiolo nomogram which normally creates five risk classes. For Candiolo classes, very-low risk and low-risk patients were pooled into the low-risk Candiolo (LRC) group, high and very high-risk patients were pooled into the high-risk Candiolo (HRC) group. The intermediate-risk Candiolo group was utilized as-is (IRC).  Mean age was 67 ± 8 years, median PSA value was 14.3 (3-211). There were 82 patients with GS ≤ 7 and 38 patients with GS ≥ 8; intermediate D'Amico class comprised 32 patients, while the high D'Amico class comprised 88 patients. For Candiolo, there were 23 LRC, 40 IRC, and 57 HRC patients. PSMA-positive metastases were detected in 44 (36.7%) patients. The SUVmean, SUVmax, PSMA-TV, and TL-PSMA values of the primary tumor demonstrated significant differences when compared according to classifications for GS, D'Amico, LRC versus HRC, and metastatic versus nonmetastatic patients. Of note, TL-PSMA was the only parameter that varied significantly among all risk groups.  Primary tumor parameters obtained from baseline Ga-PSMA PET/CT are useful to distinguish PCa patients in terms of GS, D'Amico, Candiolo nomogram, and metastatic states. TL-PSMA appears to be the best parameter as it is the only parameter that can distinguish all risk groups from each other.

摘要

本文评估了从原发性前列腺癌(PCa)病变的镓68标记前列腺特异性膜抗原(Ga-PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)成像研究中得出的参数是否与 Gleason 评分(GS)、达米科风险分类、坎迪奥洛列线图以及疾病的转移状态相关。

我们回顾性评估了治疗前接受 Ga-PSMA PET/CT 的新诊断 PCa 患者。记录了年龄、基线血清前列腺特异性抗原(PSA)和转移状态。分析了最大标准化摄取值(SUVmax)、平均 SUV(SUVmean)、总病变 PSMA(TL-PSMA)和 PSMA 衍生肿瘤体积(PSMA-TV)。患者根据 GS(GS≤7 和 GS≥8)、达米科风险分类(低、中、高风险)进行分组,并且还根据他们在通常创建五个风险类别的坎迪奥洛列线图中的结果进行分组。对于坎迪奥洛分类,极低风险和低风险患者合并为低风险坎迪奥洛(LRC)组,高风险和极高风险患者合并为高风险坎迪奥洛(HRC)组。中风险坎迪奥洛组按原样使用(IRC)。

平均年龄为 67±8 岁,PSA 中位数为 14.3(3 - 211)。有 82 例 GS≤7 的患者和 38 例 GS≥8 的患者;达米科中级组包括 32 例患者,而达米科高级组包括 88 例患者。对于坎迪奥洛分类,有 23 例 LRC 患者、40 例 IRC 患者和 57 例 HRC 患者。在 44 例(36.7%)患者中检测到 PSMA 阳性转移。根据 GS、达米科、LRC 与 HRC 以及转移与非转移患者的分类进行比较时,原发性肿瘤的 SUVmean、SUVmax、PSMA-TV 和 TL-PSMA 值显示出显著差异。值得注意的是,TL-PSMA 是所有风险组中唯一有显著差异的参数。

从基线 Ga-PSMA PET/CT 获得的原发性肿瘤参数有助于根据 GS、达米科、坎迪奥洛列线图和转移状态区分 PCa 患者。TL-PSMA 似乎是最佳参数,因为它是唯一能够区分所有风险组的参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424e/11637649/6df48d72091d/10-1055-s-0044-1787733-i2430008-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424e/11637649/fc268881f133/10-1055-s-0044-1787733-i2430008-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424e/11637649/6df48d72091d/10-1055-s-0044-1787733-i2430008-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424e/11637649/fc268881f133/10-1055-s-0044-1787733-i2430008-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424e/11637649/6df48d72091d/10-1055-s-0044-1787733-i2430008-2.jpg

相似文献

1
Baseline Ga-68 PSMA PET-Derived Primary Tumor Parameters in Patients with Prostate Cancer and Their Association with Clinical Risk Stratification and Clinicopathologic Features.前列腺癌患者基于基线镓-68前列腺特异性膜抗原正电子发射断层扫描得出的原发肿瘤参数及其与临床风险分层和临床病理特征的关联
World J Nucl Med. 2024 Jun 14;23(4):227-233. doi: 10.1055/s-0044-1787733. eCollection 2024 Dec.
2
Retrospective correlation of ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy.回顾性分析前列腺癌患者在接受根治性放疗时 Ga-PSMA 摄取与临床参数的相关性。
Ann Nucl Med. 2020 Jun;34(6):388-396. doi: 10.1007/s12149-020-01462-x. Epub 2020 Mar 27.
3
[Ga-PSMA-I&T PET/CT for assessment of tumor burden in primary lesions of treatmentnaïve prostate cancer].[镓-前列腺特异性膜抗原-免疫与靶向正电子发射断层扫描/计算机断层扫描用于评估初治前列腺癌原发灶的肿瘤负荷]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Aug 20;42(8):1143-1148. doi: 10.12122/j.issn.1673-4254.2022.08.05.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer.F-DCFPyL PET/CT在新诊断前列腺癌中的应用:前列腺内前列腺特异性膜抗原摄取在前列腺癌风险分类中的诊断价值
Front Oncol. 2022 Feb 3;12:800904. doi: 10.3389/fonc.2022.800904. eCollection 2022.
6
The Relationship between D'Amico and ISUP Risk Classifications and Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers.在新发前列腺癌中,D'Amico 与 ISUP 风险分级和 Ga-PSMA PET/CT SUVmax 值之间的关系。
Curr Oncol. 2024 Sep 8;31(9):5307-5317. doi: 10.3390/curroncol31090391.
7
68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.68Ga-PSMA-11 PET/CT 衍生的定量肿瘤体积参数可用于前列腺癌骨转移患者的分类和治疗反应评估。
Ann Nucl Med. 2019 Oct;33(10):766-775. doi: 10.1007/s12149-019-01387-0. Epub 2019 Jul 23.
8
Correlations of Ga-PSMA PET/CT in the initial staging of prostate cancer patients.前列腺癌患者初始分期的 Ga-PSMA PET/CT 相关性。
Hell J Nucl Med. 2021 Jan-Apr;24(1):60-65. doi: 10.1967/s002449912307. Epub 2021 Apr 20.
9
68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.68Ga-PSMA-11 PET/CT 在前列腺腺癌新诊断中的应用。
Clin Nucl Med. 2018 Dec;43(12):e422-e427. doi: 10.1097/RLU.0000000000002289.
10
An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external-beam radiotherapy.外部验证坎迪奥洛列线图在接受外照射放射治疗的前列腺癌患者队列中的应用。
Radiat Oncol. 2021 May 5;16(1):85. doi: 10.1186/s13014-021-01814-5.

引用本文的文献

1
Superiority of Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting.镓-PSMA-11 PET/CT在诊断腺内前列腺癌病变的定位准确性方面优于多参数磁共振成像:避免偶然靶向。
Ann Nucl Med. 2025 Jun;39(6):552-566. doi: 10.1007/s12149-025-02033-8. Epub 2025 Mar 11.

本文引用的文献

1
Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients.非转移性原发性前列腺癌患者中PSMA PET定量参数与临床危险因素的相关性
Front Oncol. 2022 Apr 22;12:879089. doi: 10.3389/fonc.2022.879089. eCollection 2022.
2
External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study.碳离子放疗联合雄激素剥夺治疗高危前列腺癌患者的 Candiolo 列线图的外部验证:一项回顾性队列研究。
Jpn J Clin Oncol. 2022 Aug 5;52(8):950-953. doi: 10.1093/jjco/hyac066.
3
An external validation of the Candiolo nomogram in a cohort of prostate cancer patients treated by external-beam radiotherapy.
外部验证坎迪奥洛列线图在接受外照射放射治疗的前列腺癌患者队列中的应用。
Radiat Oncol. 2021 May 5;16(1):85. doi: 10.1186/s13014-021-01814-5.
4
Correlations of Ga-PSMA PET/CT in the initial staging of prostate cancer patients.前列腺癌患者初始分期的 Ga-PSMA PET/CT 相关性。
Hell J Nucl Med. 2021 Jan-Apr;24(1):60-65. doi: 10.1967/s002449912307. Epub 2021 Apr 20.
5
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
6
Retrospective correlation of ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy.回顾性分析前列腺癌患者在接受根治性放疗时 Ga-PSMA 摄取与临床参数的相关性。
Ann Nucl Med. 2020 Jun;34(6):388-396. doi: 10.1007/s12149-020-01462-x. Epub 2020 Mar 27.
7
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT(proPSMA):一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
8
Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对新诊断的中高危前列腺癌的分期
Isr Med Assoc J. 2019 Feb;21(2):100-104.
9
Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients.镓-PSMA-617 PET/CT:一种有前途的新技术,可用于预测前列腺癌患者的风险分层和转移风险。
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1852-1861. doi: 10.1007/s00259-018-4037-9. Epub 2018 May 2.
10
Ga-PSMA-11 PET/CT in Newly Diagnosed Carcinoma of the Prostate: Correlation of Intraprostatic PSMA Uptake with Several Clinical Parameters.镓-PSMA-11 PET/CT在新诊断前列腺癌中的应用:前列腺内PSMA摄取与若干临床参数的相关性
J Nucl Med. 2017 Dec;58(12):1943-1948. doi: 10.2967/jnumed.117.190314. Epub 2017 Jun 15.